ReviewFrontiers in endocrinology2022

Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma.

Annette Gilchrist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.